Quarterly report [Sections 13 or 15(d)]

EARNINGS PER SHARE (Tables)

v3.25.2
EARNINGS PER SHARE (Tables)
6 Months Ended
Jun. 30, 2025
Earnings Per Share [Abstract]  
SCHEDULE OF ANTI DILUTIVE SECURITIES

The following potentially dilutive securities were excluded from the calculation of diluted net loss per share because the effects were anti-dilutive based on the application of the treasury stock method and because the Company incurred net losses during the period:

 

    2025     2024     2025     2024  
   

For the Six Months Ended

June 30,

   

For the Three Months Ended

June 30,

 
    2025     2024     2025     2024  
Convertible notes payable     1,244,852       391,659       1,244,852       297,249  
Preferred stock     641,577       301,900       641,577       301,900  
Restricted stock units     81,456       24,848       81,456       12,424  
Warrants to purchase shares of common stock     34,225       164,740       34,225       164,740  
Total potentially dilutive shares     2,002,110       883,147       2,002,110       776,313  
SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET INCOME PER SHARE

The following table sets forth the computation of basic and diluted net income per share:

 

    2025     2024     2025     2024  
    Six Months Ended June 30,     Three Months Ended June 30,  
    2025     2024     2025     2024  
                         
Net loss attributable to the common stockholders   $ (2,119,751 )   $ (1,620,471 )   $ (1,451,187 )   $ (862,383 )
                                 
Basic weighted average outstanding shares of common stock     1,605,377       1,234,241       1,605,377       1,238,085  
Dilutive effect of options and warrants     -       -       -       -  
Diluted weighted average common stock and common stock equivalents     1,605,377       1,234,241       1,605,377       1,238,085  
                                 
Loss per share:                                
Basic and diluted   $ (1.32 )   $ (1.31 )   $ (0.90 )   $ (0.70 )